The COVID-19 outbreak has rapidly spread around the world, causing a global public health and economic crisis. A critical limitation in detecting COVID-19 related pneumonia is that it is often manifested as a “silent pneumonia”, i.e., pulmonary auscultation, using a standard stethoscope, sounds "normal". Chest CT is the gold standard for detecting COVID-19 pneumonia; however, radiation exposure, availability and cost preclude its utilization as a screening tool for COVID-19 pneumonia. In this study we hypothesized that COVID-19 pneumonia, “silent” to the human ear using a standard stethoscope, is detectable using a full spectrum auscultation device that contains a machine-learning analysis.Lung sounds signals were acquired, using a novel full spectrum (3–2,000Hz) stethoscope, from 164 patients with COVID-19 pneumonia, 61 non-COVID-19 pneumonia and 141 healthy subjects. A machine-learning classifier was constructed, and the data was classified into 3 groups: 1. Normal lung sounds 2. COVID-19 pneumonia 3. Non-COVID-19 pneumonia.Standard auscultation found that 72% of the non-COVID-19 pneumonia patients had abnormal lung sounds, compared to only 25% for the COVID-19 pneumonia patients. The classifier's sensitivity and specificity for the detection of COVID-19 pneumonia were 97% and 93%, respectively, when analyzing the sound and infrasound data, and they were reduced to 93% and 80% without the infrasound data (p<0.01 difference in ROC with and without infrasound).This study reveals that useful clinical information exists in the infrasound spectrum of COVID-19 related pneumonia, and machine-learning analysis applied to the full spectrum of lung sounds is useful in its detection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.